In serine/threonine kinase 11 (STK11)-deficient LUAD, YAP directly stimulates downstream effector surviving to promote malignant progression, and YAP overexpression in the KrasG12D lung cancer mouse model accelerates tumor progression (Zhang et al., 2015). Here, STK11 is linked to neoplasm.